Podcasts, Videos, Audio Snippets
4.4K views | +0 today
Follow
 
Scooped by Pharma Guy
onto Podcasts, Videos, Audio Snippets
Scoop.it!

Anne Beale Discusses The Three Pillars of Sanofi's Patient-Centric Strategy

Anne Beale Discusses The Three Pillars of Sanofi's Patient-Centric Strategy | Podcasts, Videos, Audio Snippets | Scoop.it

Pharmaguy interviews Anne C. Beal, M.D., MPH, Chief Patient Officer, Sanofi, and Melva T. Covington, MPH, MBA., PhD, Project Leader, Research and Development, Sanofi. They talk about their roles in bringing the patient perspective into Sanofi's work to advance Sanofi's ability to deliver health care solutions that matter most to patients and those who care for them.

more...
No comment yet.
Podcasts, Videos, Audio Snippets
Podcasts, audio snippets, and interviews by PharmaGuy and other industry experts.
Curated by Pharma Guy
Your new post is loading...
Your new post is loading...
Scooped by Pharma Guy
Scoop.it!

The Coming Disruptive Digital Transformation of Pharma Marketing

Many pharmaceutical companies are operating well-established business processes that are not optimized for the digital era. This is leading to inefficiencies and missed opportunities. Arno Sosna, General Manager of Commercial Products at Veeva , describes efforts that are underway to overcome these inefficiencies and improve communications with physicians.

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Podcast: The Benefits and Risks of Limiting Pharma Sales Rep Access to Physicians

Pharmaceutical sales representatives are faced with increasingly limited access to physicians as many academic medical centers and other healthcare centers adopt conflict of interest policies restricting detailing. This is another benefit versus risk challenge for physicians who need quick access to the latest information about novel drugs.

 

For more about this, read the May 5, 2017, issue of Pharma Industry News Update here.

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Dr. Gottlieb's Comments on the Opioid Epidemic

Dr. Gottlieb's Comments on the Opioid Epidemic | Podcasts, Videos, Audio Snippets | Scoop.it

At his April 5, 2017, Senate Hearing, Dr. Scott Gottlieb, President Trump's nominee for FDA Commissioner, answered questions about the opioid epidemic by Sen. Tim Kaine, Sen. Michael Bennet, and Sen. Al Franken.

 

Listen to the Q&A here.

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

A Classic: Operation Frog - Commodore 64 Game Review

Dissecting frogs can be off-putting, so why not do it virtually? Heck, why not change state legislation so you can do so and have it count towards clas

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

An Rx Drug By Any Other Name Might Be Better for Medication Adherence

An Rx Drug By Any Other Name Might Be Better for Medication Adherence | Podcasts, Videos, Audio Snippets | Scoop.it

In this 5-minute audio snippet Pharmaguy discusses the absurdity of Rx drug names. The naming of drugs has been described both as a science and an art. Whichever, some say drug names are absurd. Drug names have been laughed at on Saturday Night Live and even cited as a reason why patients do not fill their prescriptions. And it all may be due to the overuse of 2 letters in the alphabet!

For more about this and other topics, read the March 31, 2017 Pharma Industry News Update issue published on LinkedIn:

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Big Pharma Racks Up Facebook Likes But Not So Much from Patients

Big Pharma Racks Up Facebook Likes But Not So Much from Patients | Podcasts, Videos, Audio Snippets | Scoop.it

In this 2.5-minute audio snippet, Pharmaguy contemplates how big drug companies can get hundreds of thousands of 'likes' on Facebook but score very low among patient groups worldwide. Only 25% of patients, for example, think pharma marketing is ethical. A case in point is Low-T direct-to-consumer advertising.

 

Listen here.

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

The (Near) Future of Digital Pharma: Social, Mobile, Analytics, & the Cloud

The (Near) Future of Digital Pharma: Social, Mobile, Analytics, & the Cloud | Podcasts, Videos, Audio Snippets | Scoop.it

A discussion with Philippe Kirby, former EUCAN MCM IT Director, MSD (Europe) Inc. [now Director, Customer Engagement Capabilities, MSD] about what the near future of pharma digital marketing has in store especially regarding use of the iPad, social media, and analytics in physician detailing.

 

Aired LIVE on: Wednesday, January 16, 2013

 

Questions/Topics Discussed:

  • General branded & unbranded multichannel marketing (MCM) solutions & services
  • The evolution of "eDetailing"
  • "Closed-loop marketing." What it really means.
  • 5 levels of interactivity
  • "SMAC" - social, mobile, analytics, cloud: a new enterprise IT model
more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

TransCelerating and Crowdsourcing Pharma R&D - A Critical Shift in Drug Development in the Post-Blockbuster World

TransCelerating and Crowdsourcing Pharma R&D - A Critical Shift in Drug Development in the Post-Blockbuster World | Podcasts, Videos, Audio Snippets | Scoop.it

Guests Thomas Krohn, Director, Clinical Open Innovation, Eli Lilly, Jerry Matczak, Community Manager for the Lilly Clinical Open Innovation Team, and Roland Andersson, Director for Accenture's Life Sciences R&D practice, discuss Lilly's Clinical Open Innovation project and the Transcelerate joint venture, both of which promote open source collaboration to speed development of new drugs.

Pharma Guy's insight:

According to MedCity News: 

 

Gerald “Jerry” Matczak, lead consultant in clinical innovation at Eli Lilly & Co., was a rare breed in the pharmaceutical world, someone who not only embraced social media, but also listened to activist patients.

 

Matczak died suddenly on Thursday at age 54. The cause of death was not immediately known.

 

“He didn’t show up to a meeting yesterday,” said Cathy Collette, an Indianapolis resident who advocates for patients with amyotrophic lateral sclerosis (ALS). “It was definitely unexpected and sudden.”

 

According to his LinkedIn profile, Matczak was community manager in the Clinical Open Innovation group at Eli Lilly from 2011 to 2015 before being named a consultant in clinical innovation for the pharma giant.

 

Collette called Matczak a “wonderful liaison for the pharmaceutical industry” to patients, particularly those with rare and untreatable diseases. “Jerry understood the urgency,” she said.

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

What the Pharma: Episode 3 - Drug Promotions, Patient Consumerism, and Free Speech

What the Pharma: Episode 3 - Drug Promotions, Patient Consumerism, and Free Speech | Podcasts, Videos, Audio Snippets | Scoop.it

In this special Christmas/Holiday episode, @WhatThePharma covers the drug promotions you hear on radio and TV.  Why are drugs promoted? How are they regulated? Where is the future in drug promotions and how does this affect the general patient?  High level introduction to the regulations as well as healthcare consumerism.  Two snippets of drug promos in the beginning of the episode.  Happy Holidays!

 

Please take 2 minutes to answer this survey, which solicits your opinion possible FDA future decisions regarding off-label drug promotion to patient and consumer audiences.

Your comments are confidential (anonymous) unless you specifically provide your contact information at the end of the survey and allow us to attribute comments to you personally.

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Mobile-Enabled Patient Focus Groups Demonstrate the Importance of Patients' Voices

Mobile-Enabled Patient Focus Groups Demonstrate the Importance of Patients' Voices | Podcasts, Videos, Audio Snippets | Scoop.it

WEGO Health (www.wegohealth.com), the first online home for consumer health opinion leaders,  announced a breakthrough in social consumer research with the introduction of Truvio (www.Truvio.com), the first influencer-powered, voice-response mobile research platform for the healthcare and biotechnology industries.

Truvio is powered by the WEGO Health Activist Network of more than 65,000 opted-in and vetted consumer health influencers from more than 130 health conditions and topics. Each WEGO Health Activist actively contributes to multiple online health communities. With Truvio, health consultants, researchers and companies can tap into the wisdom of these informed and passionate consumer health opinion leaders, getting on-demand feedback instead of waiting for more traditional research. Quantitative, Qualitative, and FAST Truvio's innovative mobile research platform accelerates the process of obtaining the true voice of health consumers, as the Truvio mobile platform collects results in real time and WEGO Health's hyper-engaged consumer influencer members respond quickly with informed opinions.

Health Activists complete quantitative surveys via their smartphone's keypad and are then prompted to provide qualitative comments verbally. This combination of mobile inputs improves response rates and delivers deeper results on topics that are mission-critical to researchers in a way that no standalone survey or focus group could deliver.

"Health is really social media's higher calling and with Truvio, consumer health influencers are empowered to become change agents for the millions of patients who follow them," said WEGO Health CEO Jack Barrette. "Advances in healthcare can't wait. Truvio connects industry and influencers -- fast -- in a way that benefits both."

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

The Marketing of Low T ("Low Testosterone"): Ghostwriting, Celebrities, Symptom Quizzes, Numbers

The Marketing of Low T ("Low Testosterone"): Ghostwriting, Celebrities, Symptom Quizzes, Numbers | Podcasts, Videos, Audio Snippets | Scoop.it

A conversation with Adriane Fugh-Berman, MD, Associate Professor at Georgetown University Medical Center and Director of PharmedOut. We discuss how the marketing of Androgel uses ghostwriting, celebrities, symptom quizzes, and numbers to convince men and physicians that "low testosterone" is a medical condition that should be treated.

 

Listen here.

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Zoe Elliott Dunn (@zdunnhealth) Summarizes Her Upcoming Presentation at FDA Regarding Off-Label Drug Promotion

 

Zoe Dunn, Principal at Hale Advisors, Inc., is a Digital Marketing professional with passion for helping the Pharmaceutical industry communicate via Digital Channels. She will have 8 minutes to give her presentation at FDA's Part 15 hearing on "Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products" on 9 November, 2016 (see the full list of presenters here).

 

Access the video here: https://youtu.be/4SDxIk-Vjuo

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Johnson & Johnson's ennTV: An Engaging Employee News Network

Johnson & Johnson's ennTV: An Engaging Employee News Network | Podcasts, Videos, Audio Snippets | Scoop.it

A conversation with Michael Heinley, Corporate Vice President, Leadership and Employee Communication, and Bill Price, Vice President, Media Relations, Johnson & Johnson, about the company's Employee News Network ("ennTV"), a new video news magazine produced for J&J employees worldwide.

Pharma Guy's insight:

Unfortunately, no new eppisodes have been posted since May, 2014.

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Podcast: Big Pharma Struggles to Distance Itself from "Price Gouging" Small Pharma

The drug industry is reeling from criticism about drug prices coming from all sides and especially from the president of the United States. First it tried public relations and CEO speaking tours. When that didn’t work it took more drastic action.

 

For more about this, read the May 12, 2017, issue of Pharma Industry News Update here.

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

PharmaGuy of Newtown Supports Science

PharmaGuy of Newtown Supports Science | Podcasts, Videos, Audio Snippets | Scoop.it

John (PharmaGuy) Mack was a speaker at the April 22,2017, March for Science in Doylestown, PA. He spoke of the need for more scientists to get involved in local politics and for all citizens to elect pro-science leaders and ensure that they rely on evidence, not beliefs, when making decisions about our health, our environment, and our general well-being.

 

Listen here.

more...
No comment yet.
Rescooped by Pharma Guy from Pharma Industry Regulation
Scoop.it!

Warren Goes After Gottlieb Regarding Drug Safety

Warren Goes After Gottlieb Regarding Drug Safety | Podcasts, Videos, Audio Snippets | Scoop.it

At his April 5, 2017, Senate Hearing, Dr. Scott Gottlieb, President Trump's nominee for FDA Commissioner, responded to Massachusetts Senator Elizabeth Warren's concern about his commitment to FDA's basic safety mission.

 

Listen to the exchange between Warren and Gottlieb in this 4.5-minute audio excerpt: http://bit.ly/warren-v-gott-snippet

 

Some Background

Senator Warren cited Gottlieb's comments about how the thalidomide "episode" had a lasting effect on the FDA's work. The comments appeared in a 2012 article titled "Changing the FDA's Culture." Relevant excerpts from that article include:

 

"The thalidomide episode also had a more subtle influence on the way the FDA goes about its work: It focused the agency's attention on a certain category of risks in which the problems are latent, meaning they do not become manifest until many months, and perhaps years, after exposure to a drug."

 

"This is more or less how the FDA understands its own review culture - as devoted to averting risks and protecting the public, and as being very good at doing so. This devotion comes with some downsides, to be sure: In so heavily prioritizing one of its obligations - the protection of consumers - the FDA has sometimes subordinated and neglected its other key obligation, which is to guide new medical innovations to market."

 

[Speaking at a recent conference in Seattle, Dr. Margaret Chan, director of the World Health Organization, warned against loosening the rules governing the safety and effectiveness data that drug companies must supply to win marketing approval from the FDA. Read “WHO Rebukes Trump’s FDA Critics. It’s Not a Question – It’s a Statement!”; http://sco.lt/90TQi9].

 

Further Reading:

more...
Pharma Guy's curator insight, April 6, 7:36 AM

My survey results predicted that Dr. Gottlieb would be nominated to head the FDA. See https://www.surveymonkey.com/results/SM-M77735CG/

Scooped by Pharma Guy
Scoop.it!

Making Sense of DTC Ad Spending

Making Sense of DTC Ad Spending | Podcasts, Videos, Audio Snippets | Scoop.it

In this 6-minute audio snippet, Pharmaguy talks about how much money the U.S. pharmaceutical industry spends on promoting drugs to consumers. The data come from several sources, which often report different numbers. That makes it difficult to ferret out what portion of the total is spend on TV and digital, the two most interesting channels.

 

Listen here...

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Reports of the Demise of Medical Journal Ads Have Been Greatly Exaggerated

Reports of the Demise of Medical Journal Ads Have Been Greatly Exaggerated | Podcasts, Videos, Audio Snippets | Scoop.it

In this 2.5-minute audio snippet, Pharmaguy Pharmaguy presents data from Kantar Media that shows that the death of professional print pharma advertising has been greatly exaggerated. He gets into which companies and drugs have spent the most on journal advertising and summarizes a study of physician attitudes regarding these ads.

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Shower and Flood: A Shower of Oxycodone in West Virginia, a Flood of Drug Adverse Event Reports Everywhere

Shower and Flood: A Shower of Oxycodone in West Virginia, a Flood of Drug Adverse Event Reports Everywhere | Podcasts, Videos, Audio Snippets | Scoop.it

In this 4.5-minute audio snippet, Pharmaguy discusses how West Virginia and other rural areas are being "showered" with opioids by drug companies, which could be a major cause in the current "flood" of drug adverse events. He then contemplates the potential impact of FDA loosening the ban on off-label drug promotion on serious adverse events.

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Podcast: Pharma YouTube - Successful Use of Online Video to Support Patients

Podcast: Pharma YouTube - Successful Use of Online Video to Support Patients | Podcasts, Videos, Audio Snippets | Scoop.it

Pharmaceutical marketers have a wealth of experience producing videos for direct-to-consumer (DTC) advertising (in the U.S.) and disease-awareness piblic service messages worldwide. It's no surprise, therefore, that the Dose of Digital's Pharma and Healthcare Social Media Wiki includes dozens of pharma YouTube channels, or what I like to call "YouPharma".

 

The Johnson & Johson family of companies, which includes Janssen UK, have been the leaders in launching branded and unbranded YouTube channels. This show features two of the best examples of that. Gary Monk is the person responsible for Janssen-Cilag's "Living with ADHD" YouTube site, which features a video is entitled "ADHD: A day in the life by Janssen-Cilag Ltd." Rob Halper is the person who single-handedly maintains the J&J Health Channel on YouTube, which is a non-branded site with the goal of presenting a better understanding of health and health care issues.

 

 

Questions/Topics Discussed

 

  • Describe your YouTube campaign/channel. Who is the intended audience(s)?
  • How did you get internal buy in for your digital video campaign?
  • How do you define "engagement" with patients via your YouTube channel? Do you allow comments?
  • What's your measure(s) of success?

 

Listen here.

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Only Just Begun - The Association of the British Pharmaceutical Industry - YouTube

‘Only Just Begun’ celebrates the history of the UK pharmaceutical industry in changing the lives of patients, and the people involved in its past, present and future.

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Pharmaguy's Insights on Pharma Industry News: 6 December 2016 Edition

Pharmaguy's Insights on Pharma Industry News: 6 December 2016 Edition | Podcasts, Videos, Audio Snippets | Scoop.it

Welcome to the December 6, 2016, edition of Pharma Industry News Update (aka PinUp), which is published every Tuesday as part of the Pharma Marketing News subscription service. PinUp presents selected content of topical interest from a variety of sources. 

 

Listen to this 5-minute audio synopsis here.

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Doris Peter of Consumer Reports Speaks Out Against Off-Label Promotion of Drugs by Pharma

Doris Peter of Consumer Reports Speaks Out Against Off-Label Promotion of Drugs by Pharma | Podcasts, Videos, Audio Snippets | Scoop.it

This 3.5-minute audio snippet was taken from the statements made by Dr. Doris Peter, Principal Investigator, Best Buy Drugs Project at Consumer Reports, at a November 9, 2016, FDA public hearing on off-label drug promotion by the pharmaceutical industry.

 

Listen here.

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Patients Speak For and Against Direct-to-Consumer Off-Label Promotion of Drugs

Patients Speak For and Against Direct-to-Consumer Off-Label Promotion of Drugs | Podcasts, Videos, Audio Snippets | Scoop.it

In these 2-minute audio snippets, several anonymous patients and patient advocates tell why they are in favor of or against allowing pharmaceutical companies to promote/advertise off-label uses of drugs directly to patients.

These patients were interviewed via the inVibe platform, which engages research participants on their smartphones and collects responses via automated, voice-response surveys. Learn more at www.invibe.co.

The survey was done in preparation for FDA's Part 15 public hearing on "Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products" on 9-10 November, 2016 (see here).

 

Listen to the audio snippets here.

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Novo Nordisk's Race With Insulin Campaign: It's Not Just About Twitter

Novo Nordisk's Race With Insulin Campaign: It's Not Just About Twitter | Podcasts, Videos, Audio Snippets | Scoop.it

A conversation with Ambre Morley, Associate Director, Product Communications, Novo Nordisk Inc., about Novo Nordisk's Race With Insulin Campaign, which includes a branded Twitter account (@racewithinsulin). Morley talks about Novo Nordisk's social media goals, but also about other integrated aspects of the campaign.

 

Background

According to Ross Fetterolf, VP Digital Strategy at Ignite Health, June 18, 2009, was an "Historic Day" because "diabetes patient/racecar driver Charlie Kimball produced the first pharma branded Tweet on his 'Race with Insulin' Twitter page (@racewithinsulin)." Race with Insulin was launched by Novo Nordisk to highlight its sponsorship agreement with Charlie Kimball, "the first American open-wheeled racing driver with diabetes [who provides updates] called 'tweets' directly from his computer or mobile phone about his race progress and diabetes management, representing a different direction in sharing real patient experiences."

 

But Twitter is only a tactic in Novo Nordisk's overall strategy of sharing stories of patients who use products like Levemir.

 

Questions/Topics Discussed

  • OK, it's not all about Twitter, but that's the big elephant in the room. Just tell us how you/Novo/Charlie Kimball decided to do the first-ever pharma branded Tweet?
  • How does twitter fit in with your larger "race with insulin" strategy?
  • Do you plan any other social media promotion as part of the campaign?

 

Guest Bio

Ambre Morley is responsible for public relations and issues management of Novo Nordisk's insulin portfolio and its biopharmaceutical division in the U.S. Since her arrival at the company in August 2008, Morley's achievements include securing a new spokesperson for two of the company's products: a young racecar driver with type 1 diabetes. This partnership has been successful in raising awareness that diabetes does not "slow you down" in life, and also led to the creation of the industry's first pharmaceutical-branded Twitter page. She joined Novo Nordisk in August 2008. Morley graduated summa cum laude from Tennessee State University.

 

Listen to the podcast here.

more...
No comment yet.